ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 32 filers reported holding ATYR PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $58,000 | -44.2% | 106,008 | -50.0% | 0.00% | – |
| Q4 2018 | $104,000 | +20.9% | 212,016 | +100.0% | 0.00% | – |
| Q3 2018 | $86,000 | -10.4% | 106,008 | 0.0% | 0.00% | – |
| Q2 2018 | $96,000 | -65.7% | 106,008 | 0.0% | 0.00% | – |
| Q1 2018 | $280,000 | -24.5% | 106,008 | 0.0% | 0.00% | – |
| Q4 2017 | $371,000 | -32.4% | 106,008 | -2.7% | 0.00% | – |
| Q3 2017 | $549,000 | +46.4% | 108,908 | 0.0% | 0.00% | – |
| Q2 2017 | $375,000 | -4.3% | 108,908 | -2.9% | 0.00% | – |
| Q1 2017 | $392,000 | +63.3% | 112,178 | +0.4% | 0.00% | – |
| Q4 2016 | $240,000 | -32.2% | 111,734 | +0.3% | 0.00% | – |
| Q3 2016 | $354,000 | +205.2% | 111,438 | +165.8% | 0.00% | – |
| Q2 2016 | $116,000 | -37.0% | 41,919 | -10.7% | 0.00% | – |
| Q1 2016 | $184,000 | -60.2% | 46,943 | -0.2% | 0.00% | – |
| Q4 2015 | $462,000 | +2.7% | 47,017 | +7.1% | 0.00% | – |
| Q3 2015 | $450,000 | – | 43,882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $18,755,000 | 12.78% |
| EcoR1 Capital, LLC | 840,462 | $8,623,000 | 3.92% |
| Rock Springs Capital Management LP | 388,996 | $3,991,000 | 0.32% |
| SPHERA FUNDS MANAGEMENT LTD. | 209,027 | $2,145,000 | 0.27% |
| Baker Brothers Advisors | 2,335,125 | $23,958,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 461,530 | $4,735,000 | 0.18% |
| TIVERTON ASSET MANAGEMENT LLC | 472,236 | $4,845,000 | 0.11% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,082,249 | $11,104,000 | 0.10% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 415,377 | $4,262,000 | 0.07% |
| Magnetar Financial LLC | 354,659 | $3,639,000 | 0.05% |